Novartis is fighting COVID-19 broadly, from committing R&D resources to better understand and treat the disease to reaching out to individuals and communities in need.
More than 16 teams from US universities participated in the first US oncology data science hackathon to tackle current challenges in metastatic breast cancer treatments.
On this Day of Reflection, Novartis associates are thinking and talking about what it means to be part of a truly diverse and inclusive organization.
Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.
Phil Gotwals talks about his vision for the future of business development for research.
We leave the lab to find out what people know about cell and gene therapy.
This site is intended for US Residents Only